As an oncogene, Six1 is overexpressed in colorectal cancer, breast cancer, pancreatic cancer and squamous cell carcinoma of the oesophagus and is associated with the growth, advancement and prognosis of multiple tumours.21, 41, 42, 43. Here, SIX1 is linked to pancreatic neoplasm.